SCHEMBL42011

SCHEMBL42011

Nc1ccc(C(=O)O)cn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 3/20 1.00
GABRD O14764 3/20 1.00
GABRA1 P14867 3/20 1.00
GABRB1 P18505 3/20 1.00
GABRG2 P18507 3/20 1.00
GABRB3 P28472 3/20 1.00
GABRA5 P31644 3/20 1.00
GABRA3 P34903 3/20 1.00
GABRA2 P47869 3/20 1.00
GABRB2 P47870 3/20 1.00
GABRA4 P48169 3/20 1.00
GABRE P78334 3/20 1.00
GABRA6 Q16445 3/20 1.00
GABRG1 Q8N1C3 3/20 1.00
GABRG3 Q99928 3/20 1.00
GABRQ Q9UN88 3/20 1.00
NNMT P40261 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
HDAC1 Q13547 1/20 0.62
HDAC6 Q9UBN7 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2027693 1.00 GABRP (1.00) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL29530489 1.00 GABRP (1.00) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL29056072 0.98 GABRP (0.96) GABRPGABRDGABRA1GABRB1GABRG2
Hydrochloric Acid SCHEMBL4686219 0.98 GABRP (0.96) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL30963385 0.98 GABRP (0.96) GABRPGABRDGABRA1GABRB1GABRG2
Carbamic Acid SCHEMBL9949749 0.96 GABRP (0.92) GABRPGABRDGABRA1GABRB1GABRG2
Nitrous Acid SCHEMBL22129259 0.92 GABRP (0.85) GABRPGABRDGABRA1GABRB1GABRG2
Pyridine SCHEMBL11262816 0.89 GABRP (0.79) GABRPGABRDGABRA1GABRB1GABRG2
Ether SCHEMBL27550686 0.86 GABRP (0.73) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL16853374 0.84 GABRP (0.72) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2239 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974758-B Carboxymethyl ketone compound and preparation method thereof 生物岛实验室 2025-06-10 CN claimed
CN-115650905-B Preparation method of 6-amino nicotinic acid 山西永津集团有限公司 2024-09-13 CN claimed
CN-118588380-A High-frequency anti-interference cable for test and processing technology thereof 江阴凯博通信科技有限公司 2024-09-03 CN claimed
CN-118326463-B Organic functionalized bismuth catalyst electrode and preparation method and application thereof 内蒙古工业大学 2024-08-16 CN claimed
CN-118326463-A Organic functionalized bismuth catalyst electrode and preparation method and application thereof 内蒙古工业大学 2024-07-12 CN claimed
CN-115245816-B Amino-nicotinic acid mixed mode chromatographic stationary phase and preparation method and application thereof 河北工业大学 2024-01-23 CN claimed
CN-116462896-B Sheath material for low-smoke halogen-free flame-retardant optical cable and preparation method thereof 江苏馨德高分子材料股份有限公司 2023-11-10 CN claimed
CN-115403517-B Organic-inorganic hybrid heteropolyacid solid tackifier, preparation method and dealcoholized silicone adhesive 万华化学集团股份有限公司 2023-08-11 CN claimed
CN-116462896-A Sheath material for low-smoke halogen-free flame-retardant optical cable and preparation method thereof 江苏馨德高分子材料股份有限公司 2023-07-21 CN claimed
CN-115974758-A Carboxymethyl ketone compound and preparation method thereof 生物岛实验室 2023-04-18 CN claimed
EP-0641193-A4 CHEMOTHERAPEUTIC DRUG COMBINATIONS. MARTIN DANIEL S (US) 1995-09-06 EP claimed
EP-0572560-A4 USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY. SHAPIRO HOWARD K (US) 1995-04-26 EP claimed
EP-0641193-A1 CHEMOTHERAPEUTIC DRUG COMBINATIONS PRO-NEURON, INC. (US) 1995-03-08 EP claimed
EP-0572560-A1 USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY SHAPIRO, Howard, K. (US) 1993-12-08 EP claimed
WO-1993023014-A1 CHEMOTHERAPEUTIC DRUG COMBINATIONS MARTIN DANIEL S (US) 1993-11-25 WO claimed
WO-1992014456-A1 USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY SHAPIRO HOWARD K (US) 1992-09-03 WO claimed
EP-0113242-B1 CEPHALOSPORIN DERIVATIVES KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1989-11-08 EP claimed
EP-0113242-A2 Cephalosporin derivatives KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1984-07-11 EP claimed
US-4375545-A Process for the synthesis of the nicotinyl ester of 6-aminonicotinic acid WESTWOOD PHARMACEUTICALS, INC. (US) 1983-03-01 US claimed
US-4141977-A Treatment of psoriasis with 6-substituted nicotinamides, 2-substituted pyrazinamides and closely related compounds YU RUEY J 1979-02-27 US claimed